All News #Library
Biotech
Alar Reports Positive Phase 1 Ketamine Therapy Results
06 Apr 2026 //
PR NEWSWIRE
Alar Announces ALA-1000`s Efficacy, Safety in Canine OA Study
16 Mar 2026 //
PR NEWSWIRE

Market Place
Sourcing Support